Several studies have demonstrated the protective roles of NRF2 activation in various kidney diseases, including acute kidney injury, diabetic nephropathy, and CKD, making it a promising therapeutic target for kidney diseases [41,42,43]. Here, NFE2L2 is linked to chronic kidney disease.